You are viewing the site in preview mode
Skip to main content
|
Patient characteristics
|
n (%)
|
|---|
|
Age
|
|
Median (years)
|
61
|
|
Range (years)
|
29–82
|
|
Sex
|
|
male/female
|
15 (63) / 9 (38)
|
|
Disease
|
|
ALL
|
11 (46)
|
|
BCP-ALL
|
10
|
|
T-ALL
|
1
|
|
AML
|
12 (50)
|
|
CML-BP
|
1 (4)
|
|
Extramedullary disease
|
5 (21)
|
|
SCT prior to study therapy
|
16 (67)
|
|
SCT in AML patients
|
6
|
|
SCT in ALL patients
|
9
|
|
SCT in CML-BP patient
|
1
|
- Baseline patient characteristics reveal a median age of 61 and mainly patients with BCP-ALL and AML, who previously in most cases underwent an allogeneic SCT
